With prices in a downtrend with a $95 price target, hold off on purchases until prices hold for the drugmaker.
Here's how to play this stock.
A check-up on six healthcare ideas that remain favorites for the remainder of 2019.
ABMD has been one of the best-performing stocks in the S&P 500 over the past five years.
All the charts of the molecular diagnostics company look bullish.
EW has had some corrections and pullbacks along the way during this long and strong rally from $80 to nearly $200, but its price target is $240.
Let's look at the charts and indicators.
Here's an updated strategy.
The stock has been bouncing off the 200-day moving average line.
It may pay to keep this one on your future shopping list.